Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Accured Expenses: 2019-2024

Historic Change in Accured Expenses for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to $15.0 million.

  • LifeStance Health's Change in Accured Expenses fell 7816.17% to -$17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 27983.09%. This contributed to the annual value of $15.0 million for FY2024, which is 4342.24% down from last year.
  • According to the latest figures from FY2024, LifeStance Health's Change in Accured Expenses is $15.0 million, which was down 4342.24% from $26.5 million recorded in FY2023.
  • LifeStance Health's Change in Accured Expenses' 5-year high stood at $39.6 million during FY2021, with a 5-year trough of $12.1 million in FY2022.
  • For the 4-year period, LifeStance Health's Change in Accured Expenses averaged around $23.3 million, with its median value being $20.7 million (2023).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 6943.36% in 2022, then surged by 11887.6% in 2023.
  • LifeStance Health's Change in Accured Expenses (Annual) stood at $39.6 million in 2021, then plummeted by 69.43% to $12.1 million in 2022, then surged by 118.88% to $26.5 million in 2023, then tumbled by 43.42% to $15.0 million in 2024.
  • Its last three reported values are $15.0 million in FY2024, $26.5 million for FY2023, and $12.1 million during FY2022.